Advanced Oncotherapy (AVO) has raised £2.7m in a new share issue aimed at obtaining regulatory approval for its first LIGHT system. The company said the funds would be used to progress its verification and validation activity ahead of the opening of its Harley Street site in 2020. The move follows AVO’s £20m fundraise in September. A…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
 has raised £2.7m in a new share issue to help the AIM-listed company obtain regulatory approval for its first LIGHT system.){kind=link}